Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Favalli C, Syrjänen K
Unità Citoistopatologia, Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità (ISS), Rome, Italy.
J Clin Pathol. 2006 Oct;59(10):1044-51. doi: 10.1136/jcp.2005.033142. Epub 2006 Mar 14.
One of the factors leading to an invasive phenotype is the nm23 family of metastases-associated genes. Of the six known members, nm23-H1 is the most frequently studied potential anti-metastatic gene in cervical cancer. However, the possible molecular links to oncogenic human papillomavirus (HPV) are completely unexplored as yet.
As a part of the HPV-Pathogen Istituto Superiore di Sanità study, a series of 150 squamous cell carcinomas (SCCs) and 152 cervical intraepithelial neoplasia (CIN) lesions were examined by immunohistochemical staining for nm23-H1, and tested for HPV by polymerase chain reaction (PCR) with three sets of primers (MY09/11, GP5(+)/GP6(+) and short PCR fragment). Follow-up data were available on all patients with SCC, and 67 CIN lesions were monitored by serial PCR for clearance or persistence of HPV after cone treatment.
A linear decrease (p = 0.001) was observed in nm23-H1 expression, starting from CIN1 (85% with normal expression), with the most dramatic down regulation on transition from CIN2 (70% normal) to CIN3 (39%) and further to SCC (25%). Reduced expression was associated with CIN3 or cancer at an odds ratio 8.72 (95% confidence interval 4.13 to 18.41). Nm23-H1 was of no use as a marker of the high-risk human papillomavirus (HR-HPV) type, and it did not predict clearance or persistence of HR-HPV after treatment of CIN. Importantly, nm23-H1 expression was a significant prognostic factor in cervical cancer, reduced expression being associated with lower survival (p = 0.022) in univariate analysis. In the multivariate (Cox) regression model, however, only the International Federation of Gynecology and Obstetrics stage (p = 0.001) and age (p = 0.011) remained independent prognostic predictors.
Down-regulated nm23-H1 expression is markedly associated with progression from CIN2 to CIN3, and predicts poor prognosis in cervical cancer. Nm23-H1 down regulation is probably orchestrated by mechanisms independent of HR-HPV oncoproteins and is possibly related to the emergence of a proteolytic phenotype.
导致侵袭性表型的因素之一是转移相关基因nm23家族。在已知的六个成员中,nm23-H1是宫颈癌中研究最频繁的潜在抗转移基因。然而,其与致癌性人乳头瘤病毒(HPV)之间可能的分子联系尚未得到充分探索。
作为HPV-病原体罗马国家高等卫生研究院研究的一部分,通过免疫组织化学染色检测150例鳞状细胞癌(SCC)和152例宫颈上皮内瘤变(CIN)病变中的nm23-H1,并使用三组引物(MY09/11、GP5(+)/GP6(+)和短PCR片段)通过聚合酶链反应(PCR)检测HPV。所有SCC患者均有随访数据,67例CIN病变在锥形治疗后通过连续PCR监测HPV的清除或持续情况。
从CIN1(85%表达正常)开始,观察到nm23-H1表达呈线性下降(p = 0.001),从CIN2(70%正常)转变为CIN3(39%)再到SCC(25%)时下调最为显著。表达降低与CIN3或癌症相关,比值比为8.72(95%置信区间4.13至18.41)。Nm23-H1不能作为高危人乳头瘤病毒(HR-HPV)类型的标志物,也不能预测CIN治疗后HR-HPV的清除或持续情况。重要的是,nm23-H1表达是宫颈癌的一个重要预后因素,在单变量分析中,表达降低与较低的生存率相关(p = 0.022)。然而,在多变量(Cox)回归模型中,只有国际妇产科联盟分期(p = 0.001)和年龄(p = 0.011)仍然是独立的预后预测因素。
nm23-H1表达下调与CIN2进展为CIN3显著相关,并预测宫颈癌预后不良。Nm23-H1下调可能由独立于HR-HPV癌蛋白的机制调控,可能与蛋白水解表型的出现有关。